Prevalence and genotype distribution of human papillomavirus infection among 66000 women from 2014 to 2023 in the plateau region of Southwest China.

Autor: Hu JP; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Wang JL; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Li Y; Department of Anesthesiology, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Feng Y; Department of Gynaecology, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Tian CQ; Department of Public Health and Preventive Medicine, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Zhang GH; Deparment of UItrasonic Diagnosis, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Chen XQ; Department of Gynaecology, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Liu HX; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Yang JS; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Fang ZW; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Li YX; Deparment of UItrasonic Diagnosis, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Wu ZS; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Zhu R; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Li XP; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Xiong Q; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Gao LH; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Ji T; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Zhang JD; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Song JM; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Chen Q; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Li SM; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., He F; Deparment of Orthopedics, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China., Yang CJ; School of Basic Medical Sciences, Qujing Medical College, Qujing, 655011, China. 3651558@qq.com., Li HW; Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, 655000, China. lihongwei@kmmu.edu.cn.
Jazyk: angličtina
Zdroj: Virology journal [Virol J] 2024 Aug 06; Vol. 21 (1), pp. 176. Date of Electronic Publication: 2024 Aug 06.
DOI: 10.1186/s12985-024-02447-2
Abstrakt: Background: Persistent infection with high-risk human papillomavirus (HR-HPV) plays a key role in the onset of cervical cancer. This study was designed to examine the epidemiological trends and genotype distribution of HPV from 2014 to 2023 in the plateau region of Southwest China.
Methods: The findings could offer valuable insights for clinical screening of cervical cancer and the formulation of HPV vaccination policies. This retrospective study analyzed 66,000 women who received HPV-DNA testing at the First People's Hospital of Qujing, Yunnan, China, between 2014 and 2023. The cohort consisted of 33,512 outpatients, 3,816 inpatients, and 28,672 individuals undergoing health examinations. Cervical cells were collected for DNA extraction, and PCR amplification along with Luminex xMAP technology were used to detect 27 HPV genotypes. The data analysis was conducted using GraphPad Prism and IBM SPSS Statistics 27 software.
Results: The overall HPV infection rate at the First People's Hospital of Qujing declined from 24.92% in 2014 to 16.29% in 2023, averaging 16.02%. Specific infection rates were 18.50% among outpatients, 12.97% among inpatients, and 13.53% for health examination attendees. The predominant high-risk HPV genotypes identified were HPV52 (2.61%), HPV16 (2.06%), HPV58 (1.81%), HPV53 (1.55%), and HPV39 (1.09%). Meanwhile, the most frequent low-risk HPV genotypes were HPV6 (1.30%), HPV61 (1.21%), and HPV11 (0.85%). In HPV-positive cases, the distribution of single, double, triple, and quadruple or more infections were 79.90%, 15.17%, 3.59%, and 1.33%, respectively. The proportions of pure LR-HPV, pure HR-HPV, and mixed infections were 22.16%, 67.82%, and 10.02%, respectively. Age-specific analysis revealed a bimodal distribution of HPV infection, with the infection rate rapidly decreasing from 44.02% in the ≤ 19 age group to 19.55% in the 20-29 age group and 13.84% in the 30-39 age group, followed by a gradual increase to 14.64% in the 40-49 age group, 16.65% in the 50-59 age group, and 22.98% in the ≥ 60 age group. The coverage rates of the three available vaccines are all below 50%. The results of this study indicated a declining trend in HPV prevalence in the plateau region of Southwest China over the period from 2014 to 2023, especially in the reduction of genotypes targeted by vaccines.
Conclusion: There were significant variations in the genotypes prevalent among different age groups, years, and patient sources within the same region. The underwhelming vaccination rates emphasize the critical need for developing either a multivalent vaccine or a personalized vaccine that targets the HPV genotypes common in the Chinese population. Furthermore, vaccinating adolescents to curb HPV infection and ensuring regular cervical cancer screenings for postmenopausal women are crucial steps.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje